55KRC: UC studies sickle cell's effect on neurological conditions
Sickle cell disease, a genetic blood disorder that primarily affects people of African ancestry, can cause a variety of symptoms, including muscle pain, nonhealing ulcers, stroke and cognitive impairment.
Hyacinth I. Hyacinth, PhD, MBBS, associate professor of neurology and rehabilitation medicine and the Whitaker and Price Chair in Brain Health in UC’s College of Medicine, joined 55KRC's Simply Medicine program to discuss his research into how sickle cell disease affects stroke and cognitive impairment.
Hyacinth explained that children as young as two with sickle cell disease are at risk for stroke, and children as young as three with sickle cell can have cognitive impairment.
"So that in itself makes it a heartbreaking complication, because when you see a five-year-old with a stroke, it’s heart wrenching," he told Simply Medicine.
Cognitive impairment is in part caused by inflammation in the brain, and Hyacinth's lab recently received new grant funding to test if a drug can help "turn down" the inflammation and reduce cognitive impairment.
Listen to the Simply Medicine interview. (Note: Segment begins around 9:30 mark of program.)
Read more about Hyacinth's research.
Featured photo at top of Hyacinth working in his lab. Photo/Andrew Higley/UC Marketing + Brand.
Related Stories
What is a trademark?
August 11, 2026
Sean Owens, an adjunct professor in the Donald P. Klekamp College of Law, discussed trademark law with the Dayton Daily News. Owens is also a partner at intellectual property law firm Wood Herron & Evans in Cincinnati.
UC radiation oncologist speaks with Local 12 news about clinical trial for head and neck cancer treatment
August 10, 2026
Dr. Sara Medek, a UC radiation oncology professor, speaks with Local 12 news about a new clinical trial aimed at reducing radiation in certain areas while still treating cancer effectively but with fewer painful side effects.
Cancer Center director charts future based on collaboration, AI
August 10, 2026
David Gius, MD, PhD, was featured in a Cincinnati Business Courier article and The Cancer Letter’s “The Directors" podcast discussing his priorities and goals as he recently took the helm as director of the University of Cincinnati Cancer Center.